Reference health

Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension

https://doi.org/10.1161/hypertensionaha.117.10655
CiteStamped reference-health badge
2 of 35 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1013/S1474-4422(14)70049-3
does not resolve to a known work10.1097/01.TP.0000021368.09132.D6
The 33 checked references that resolve
resolves10.1111/j.1476-5381.2011.01260.x
Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system
resolves10.1146/annurev-physiol-021014-071635
Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient
resolves10.1016/j.ahj.2014.06.028
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
resolves10.1056/NEJMoa0909494
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
resolves10.1111/j.1523-1755.2004.00906.x
Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis
resolves10.1152/ajprenal.00311.2005
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney
resolves10.1681/ASN.2009060662
Activation of Sphingosine-1-Phosphate 1 Receptor in the Proximal Tubule Protects Against Ischemia-Reperfusion Injury
resolves10.1152/ajprenal.90530.2008
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \({5}/{6}\) \end{document} nephrectomized rats
resolves10.3109/0886022X.2013.809006
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats
resolves10.1152/ajprenal.90617.2008
The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy
resolves10.1007/s11033-011-0750-1
The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis
resolves10.1681/ASN.2013121351
Sphingosine 1-Phosphate Receptor-1 Enhances Mitochondrial Function and Reduces Cisplatin-Induced Tubule Injury
resolves10.1177/1352458509357065
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
resolves10.1016/j.bbrc.2008.03.144
FTY720 inhibits S1P-mediated endothelial healing: Relationship to S1P1-receptor surface expression
resolves10.1161/01.RES.36.2.300
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.
resolves10.1046/j.1523-1755.2003.00929.x
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
resolves10.1161/HYPERTENSIONAHA.107.104901
Spironolactone Suppresses Peritubular Capillary Loss and Prevents Deoxycorticosterone Acetate/Salt-Induced Tubulointerstitial Fibrosis
resolves10.1126/science.275.5302.964
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
resolves10.1038/ki.1997.318
A new model of renal microvascular endothelial injury
resolves10.1093/ndt/gfm774
A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy
resolves10.1016/S0092-8674(00)81661-X
Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate
resolves10.1161/hq0102.101843
Involvement of Endothelial Nitric Oxide in Sphingosine-1-Phosphate–Induced Angiogenesis
resolves10.1172/JCI1560
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
resolves10.1073/pnas.1934494100
VEGF induces S1P <sub>1</sub> receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors
resolves10.1161/HYPERTENSIONAHA.117.09088
S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure
resolves10.1126/science.1070238
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
resolves10.1371/journal.pone.0052985
The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat
resolves10.1111/j.1476-5381.2012.01865.x
FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase
resolves10.1111/jth.12681
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study
resolves10.1152/ajprenal.00025.2010
Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney
resolves10.1371/journal.pone.0032380
FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells
resolves10.1056/NEJMoa0907839
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
resolves10.1007/s11912-012-0242-z
VEGF Inhibition, Hypertension, and Renal Toxicity
The 1 reference without a DOI — listed, not checked
no DOI — not checkedChun, J, Brinkmann, V. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). Discov Med. 2011;12:213–228.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1161/hypertensionaha.117.10655"><img src="https://citestamp.com/citestamped/10.1161/hypertensionaha.117.10655/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1161/hypertensionaha.117.10655/badge.svg)](https://citestamp.com/citestamped/10.1161/hypertensionaha.117.10655)